CEO and Investigator In-Chief Urological Research Network, Miami-FL
Urology
Dr. Fernando J. Bianco Jr., MD
|
|
Give Review
Fernando Bianco works in the field of Urology. He studied medicine at Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. He over the years received 7 awards: "Executive Board Representative to AJCC", "President, Young Urologist Oncology Section", "Honorary member", "Prostate Cancer Foundation Award for Best Clinical Paper", "Prostate Cancer Foundation Award - Runner Up Best Clinical Paper", "Merit Award" and "Outcomes Research Scholar". Fernando J. Bianco Jr. is a published doctor. He published 62 publications, including: 'The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.' He is registered with Medicare and accepts Medicare payments.
Publications
- Oncocytoma of the adRenal gland medulla.
- The role of cannabinoids in prostate Cancer: Basic science perspective and potential clinical applications.
- Emerging biomarkers for prostate Cancer diagnosis, staging, and prognosis.
- Robotic radical Prostatectomy: present and future.
- Surgery confounds biology: the predictive value of stage-, grade- and Prostate-specific antigen for recurrence after radical Prostatectomy as a function of surgeon exp...
- Posterior rhabdosphincter reconstruction during robotic assisted radical Prostatectomy: results from a phase II randomized clinical trial.
- Prognostic impact of the 2009 UICC/AJCC TNM staging system for Renal cell carcinoma with venous extension.
- Pelvic neuroanatomy and radical Prostatectomy with neurovascular preservation: quo vadis?
- Surgical anatomy of radical Prostatectomy: periprostatic fascial anatomy and overview of the urinary sphincters.
- Fellowship training as a modifier of the surgical learning curve.
- Variations among experienced surgeons in Cancer control after open radical prostatectomy.
- Prostate Cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
- Prevalence of erectile dysfunction in men screened for prostate Cancer.
- Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate Cancer.
- Comparison of models to predict clinical failure after radical Prostatectomy.
- Is it necessary to remove the seminal vesicles completely at radical Prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.
- Glassy cell carcinoma of the urethra.
- Paradigms in androgen/castrate resistant states of prostate Cancer in a biomarker era.
- Surgeon experience is strongly associated with biochemical recurrence after radical Prostatectomy for all preoperative risk categories.
- Prospective intermediate follow-up of carcinoma in situ involving the distal ureter at cystectomy: is there a role for ureteroscopy?
- Radical Prostatectomy: surgical planning, execution, and outcomes.
- Low risk prostate Cancer in men under age 65: the case for definitive treatment.
- Radical prostatectomy for clinically localized, high risk prostate Cancer: critical analysis of risk assessment methods.
- The surgical learning curve for prostate Cancer control after radical prostatectomy.
- Improved prediction of prostate Cancer recurrence through systems pathology.
- The anatomical and pathological characteristics of irradiated prostate Cancers may influence the oncological efficacy of salvage ablative therapies.
- Complete resection of seminal vesicles at radical Prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
- Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience.
- The anterior layer of Denonvilliers' fascia: a common misconception in the laparoscopic Prostatectomy literature.
- Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate Cancer.
- Poorly differentiated prostate Cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.
- Defining biochemical recurrence of prostate Cancer after radical prostatectomy: a proposal for a standardized definition.
- Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate Cancer.
- Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
- Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
- Preoperative nomogram predicting the 10-year probability of prostate Cancer recurrence after radical prostatectomy.
- The association between total and positive lymph node counts, and disease progression in clinically localized prostate Cancer.
- Does a delay between diagnosis and radical Prostatectomy increase the risk of disease recurrence?
- Patient opinion of urologists' reimbursement.
- Radical prostatectomy: long-term Cancer control and recovery of sexual and urinary function ("trifecta").
- Postoperative nomogram predicting the 10-year probability of prostate Cancer recurrence after radical prostatectomy.
- Testosterone as a predictor of pathological stage in clinically localized prostate Cancer.
- Variations among high volume surgeons in the rate of complications after radical Prostatectomy: further evidence that technique matters.
- Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate Cancer after radiotherapy.
- Pattern of Prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical Prostatectomy.
- Stent-change therapy in advanced malignancies with ureteral Obstruction.
- Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate Cancer after radiation therapy.
- PSA velocity and prostate Cancer.
- Salvage therapy for locally recurrent prostate Cancer after external beam radiotherapy.
- Contemporary impact of transrectal ultrasound lesions for prostate Cancer detection.
- Management of clinical T1 Bladder transitional cell carcinoma by radical cystectomy.
- The effect of race/ethnicity on prostate Cancer treatment outcome is conditional: a review of Wayne State University data.
- Recurrent scrotal arteriovenous malformation.
- Biliary peritonitis complicating percutaneous nephrolithomy requiring laparoscopic cholecystectomy.
- Radical Prostatectomy nomograms in black American men: accuracy and applicability.
- Incidence and significance of positive urine cultures in patients with an orthotopic neoBladder.
- Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate Cancer.
- Deep venous thrombosis due to compression of external iliac vein by the penile prosthesis reservoir.
- Prostate Cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
- Presence of circulating prostate Cancer cells in African American males adversely affects survival.
- Comparison of costs and complications of radical and partial nephrectomy for treatment of localized Renal cell carcinoma.
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystometry
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Executive Board – Representative to AJCC
- President, Young Urologist Oncology Section
- Honorary member
- Prostate Cancer Foundation Award for Best Clinical Paper
- Prostate Cancer Foundation Award - Runner Up Best Clinical Paper
- Merit Award
- Outcomes Research Scholar
Education
-
Memorial Sloan-Kettering Cancer Center -
Wayne State University School of Medicine -
Central University of Venezuela
Helpful Reviews
Similar Doctors
|
|
Dr. Edward L. Gheiler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ghassan Hamady, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julian A. Yong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Small, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guillermo Vazquez, MD |
|
|
Dr. Ariel M. Kaufman, MD |